Your Input: | |||||
MAPK1 | Mitogen-activated protein kinase. (380 aa) | ||||
MYC | Myc proto-oncogene protein; Transcription factor that binds DNA in a non-specific manner, yet also specifically recognizes the core sequence 5'-CAC[GA]TG-3'. Activates the transcription of growth-related genes. (439 aa) | ||||
RET | Proto-oncogene tyrosine-protein kinase receptor Ret; Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation upon binding with glial cell derived neurotrophic factor family ligands. (1113 aa) | ||||
MAP2K2 | Dual specificity mitogen-activated protein kinase kinase 2 isoform X1; Belongs to the protein kinase superfamily. (400 aa) | ||||
TCF7L1 | Transcription factor 7-like 1 isoform X1. (601 aa) | ||||
TPM3 | Tropomyosin alpha-3 chain isoform X5; Belongs to the tropomyosin family. (284 aa) | ||||
NTRK1 | Tyrosine-protein kinase receptor. (795 aa) | ||||
GADD45G | Growth arrest and DNA damage-inducible protein GADD45 gamma. (159 aa) | ||||
LOC111168952 | Peroxisome proliferator-activated receptor gamma; Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut ho [...] (933 aa) | ||||
CTNNB1 | Catenin beta-1. (781 aa) | ||||
CCDC6 | Coiled-coil domain-containing protein 6. (476 aa) | ||||
HRAS | GTPase HRas isoform X1. (189 aa) | ||||
GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta. (160 aa) | ||||
LEF1 | Lymphoid enhancer-binding factor 1 isoform X1. (414 aa) | ||||
NCOA4 | Nuclear receptor coactivator 4 isoform X1. (625 aa) | ||||
RXRG | Retinoic acid receptor RXR-gamma isoform X1. (463 aa) | ||||
TCF7L2 | Transcription factor 7-like 2 isoform X1. (668 aa) | ||||
LOC111174776 | Tropomyosin alpha-3 chain-like. (185 aa) | ||||
KRAS | GTPase KRas. (188 aa) | ||||
RXRA | Retinoic acid receptor RXR-alpha isoform X1. (495 aa) | ||||
BAK1 | Bcl-2 homologous antagonist/killer isoform X1. (239 aa) | ||||
BRAF | Serine/threonine-protein kinase B-raf isoform X1. (762 aa) | ||||
GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha. (165 aa) | ||||
CDKN1A | Cyclin-dependent kinase inhibitor 1. (164 aa) | ||||
MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1; Belongs to the protein kinase superfamily. (393 aa) | ||||
RXRB | Retinoic acid receptor RXR-beta isoform X1. (538 aa) | ||||
BAX | Apoptosis regulator BAX isoform X2. (223 aa) | ||||
CDH1 | Cadherin-1; Cadherins are calcium-dependent cell adhesion proteins. (885 aa) | ||||
NRAS | GTPase NRas. (189 aa) | ||||
TCF7 | Transcription factor 7 isoform X1. (415 aa) | ||||
MAPK3 | Mitogen-activated protein kinase; Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. MAP kinase subfamily. (382 aa) | ||||
CCND1 | G1/S-specific cyclin-D1; Belongs to the cyclin family. (295 aa) | ||||
TFG | Protein TFG isoform X1. (400 aa) | ||||
TPR | Nucleoprotein TPR isoform X2. (2438 aa) | ||||
DDB2 | DNA damage-binding protein 2 isoform X1. (457 aa) | ||||
POLK | DNA polymerase kappa. (878 aa) | ||||
PAX8 | Paired box protein Pax-8. (457 aa) | ||||
TP53 | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression. Its pro-apoptotic activity is activated via its intera [...] (387 aa) |